PATENT CLAIM ANALYSIS

Application Number: 15984281
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["540", "494000"]

Abstract:
This disclosure provides novel isoquinolidinobenzodiazepines. These compounds can also be incorporated into antibody-drug conjugates.

Claim (Index 77):
The antibody-drug conjugate of  claim 65 , wherein the drug is conjugated to the non-natural cysteine residue.

Metadata:
- Claim Count in Document: 64.0
- Percentile: 93.0
- Lexical Diversity: 1.06667
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335164', '15048865', '15904265', '13397195', '14849270']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7107777842819496
- 35 USC 102 Novelty (BERT): 0.6077003286283894
- Combined Prediction Score: 0.7004700387165936
- Mean Citation Score: 415.354686
- Max Citation Score: 569.9697
- Similarity Product: 436.602991738379

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test